Connection

Kenneth Dinnon to Clinical Trials, Phase III as Topic

Back to Details
This is a "connection" page, showing publications Kenneth Dinnon has written about Clinical Trials, Phase III as Topic.
Kenneth Dinnon
Connection Strength
0.079
Clinical Trials, Phase III as Topic
  1. SARS-CoV-2 infection is effectively treated and prevented by EIDD-2801. Nature. 2021 03; 591(7850):451-457.
    View in: PubMed
    Score: 0.040
  2. SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness. Nature. 2020 10; 586(7830):567-571.
    View in: PubMed
    Score: 0.039
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.